Related Experiment Video
Updated: Oct 29, 2025
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
The Role of Antiphospholipid Antibodies in COVID-19
Maximilian Stelzer1, Jörg Henes2, Sebastian Saur3
1School of Medicine, University of Tuebingen, Tuebingen, Germany.
Insights
Elevated anti-phospholipid (aPL) antibodies are linked to anti-phospholipid syndrome (APS) and thrombosis. This review examines the presence and significance of aPL antibodies in COVID-19 patients, questioning their correlation.
Area of Science:
- Immunology
- Virology
- Rheumatology
Background:
- Anti-phospholipid (aPL) antibodies are key diagnostic markers for anti-phospholipid syndrome (APS), a condition associated with thrombotic events.
- The coronavirus disease 2019 (COVID-19) pandemic has seen the detection of aPL antibodies in a significant number of patients, prompting investigation into a potential link.
Purpose of the Study:
- To review and compare existing studies on the occurrence and significance of aPL antibodies in COVID-19 patients.
- To explore the potential relationship between aPL antibodies, COVID-19, and anti-phospholipid syndrome (APS).
Main Methods:
- Comparative analysis of published studies investigating aPL antibodies in COVID-19 cohorts.
- Review of data on the prevalence and clinical implications of aPL antibodies in relation to COVID-19 severity and thrombotic risk.
Main Results:
- Studies show varying degrees of aPL antibody positivity in COVID-19 patients.
- Ambivalent findings exist regarding the substantial correlation and clinical significance of aPL antibodies in the context of COVID-19.
Conclusions:
- Further research is necessary to clarify the role of aPL antibodies in COVID-19.
- Larger studies are required to establish the significance of aPL antibodies and their potential link to anti-phospholipid syndrome (APS) in COVID-19 patients.
Purpose Of The Review:
Elevated levels of anti-phospholipid (aPL) antibodies are the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are usually responsible for promoting the risk of thrombotic complications. Now, in the course of the global coronavirus disease 2019 (COVID-19) pandemic, measurable aPL antibodies have also been detected in a noticeable number of patients showing a variety ranging from studies with only isolated positive tests to cohorts with very high positivity. Thus, the question arises as to whether these two different clinical pictures may be linked.
Recent Findings:
The ambivalent results showed a frequent occurrence of the investigated aPL antibodies in COVID-19 patients to an individually varying degree. While some question a substantial correlation according to their results, a number of studies raise questions about the significance of a correlation of aPL antibodies in COVID-19 patients. Within the scope of this review, these have now been described and compared with each other. Ultimately, it is necessary to conduct further studies that specifically test aPL antibodies in a larger context in order to make subsequent important statements about the role of APS in COVID-19 and to further strengthen the significance of the described comparisons.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:26Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:14Myocarditis III: Medical Management
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...